Characterization of hepatitis B virus mutations in untreated patients co-infected with HIV and HBV based on complete genome sequencing

Journal of Medical Virology

Volumn 85, Issue 1, 2013, Pages 16-25

  Tangkijvanich, Pisit ^a   Sa Nguanmoo, Pattaratida ^a   Avihingsanon, Anchalee ^a,b   Ruxrungtham, Kiat ^a,b   Poovorawan, Kittiyod ^a   Poovorawan, Yong ^a  

^a CHULALONGKORN UNIVERSITY   (Thailand)

^b THAI RED CROSS AIDS RESEARCH CENTRE   (Thailand)

Author keywords

Genome sequencing; Genotypes; Hepatitis B virus; HIV; Mutations; Recombination

Indexed keywords

HEPATITIS B(E) ANTIGEN;

ADULT; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENE MUTATION; GENE SEQUENCE; GENOME; GENOTYPE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; MIXED INFECTION; NONHUMAN; NUCLEOTIDE SEQUENCE; PREVALENCE; PROMOTER REGION; THAILAND;

ADULT; COINFECTION; DNA, VIRAL; FEMALE; GENOME, VIRAL; GENOTYPE; HEPATITIS B; HEPATITIS B VIRUS; HIV INFECTIONS; HUMANS; MALE; MOLECULAR SEQUENCE DATA; MUTATION; MUTATION RATE; SEQUENCE ANALYSIS, DNA; VIRAL LOAD;

HEPATITIS B VIRUS;

EID: 84869237432     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.23430     Document Type: Article

References (29)

1. Audsley J, Littlejohn M, Yuen L, Sasadeusz J, Ayres A, Desmond C, Spelman T, Lau G, Matthews GV, Avihingsanon A, Seaberg E, Philp F, Saulynas M, Ruxrungtham K, Dore GJ, Locarnini SA, Thio CL, Lewin SR, Revill PA. 2010. HBV mutations in untreated HIV-HBV co-infection using genomic length sequencing. Virology 405:539-547.
2. Cassino L, Laufer N, Salomon H, Campos R, Quarleri J. 2009. Hepatitis B precore/core promoter mutations in isolates from HBV-monoinfected and HBV-HIV coinfected patients: A 3-yr prospective study. J Clin Virol 46:354-359.
3. Chen BF, Liu CJ, Jow GM, Chen PJ, Kao JH, Chen DS. 2006. High prevalence and mapping of pre-S deletion in hepatitis B virus carriers with progressive liver diseases. Gastroenterology 130:1153-1168.
4. Chen C, Hung C, Lee C, Hu T, Wang J, Wang J, Lu S, Changchien C. 2007. Pre-S deletion and complex mutations of hepatitis B virus related to advanced liver disease in HBeAg-negative patients. Gastroenterology 133:1466-1474.
5. Choi MS, Kim DY, Lee DH, Lee JH, Koh KC, Paik SW, Rhee JC, Yoo BC. 2007. Clinical significance of pre-S mutations in patients with genotype C hepatitis B virus infection. J Viral Hepat 14:161-168.
6. Coleman PF. 2006. Detecting hepatitis B surface antigen mutants. Emerg Infect Dis 12:198-203.
7. Colin JF, Cazals-Hatem D, Loriot MA, Martinot-Peignoux M, Pham BN, Auperin A, Degott C, Benhamou JP, Erlinger S, Valla D, Marcellin P. 1999. Influence of human immunodeficiency virus infection on chronic hepatitis B in homosexual men. Hepatology 29:1306-1310.
8. Dao DY, Balko J, Attar N, Neak E, Yuan HJ, Lee WM, Jain MK. 2011. Hepatitis B virus genotype G: Prevalence and impact in patients co-infected with human immunodeficiency virus. J Med Virol 83:1551-1558.
9. Ghany M, Liang TJ. 2007. Drug targets and molecular mechanisms of drug resistance in chronic hepatitis B. Gastroenterology 132:1574-1585.
10. Hsieh YH, Su IJ, Wang HC, Chang WW, Lei HY, Lai MD, Chang WT, Huang W. 2004. Pre-S mutant surface antigens in chronic hepatitis B virus infection induce oxidative stress and DNA damage. Carcinogenesis 25:2023-2032.
11. Joshi D, O'Grady J, Dieterich D, Gazzard B, Agarwal K. 2011. Increasing burden of liver disease in patients with HIV infection. Lancet 377:1198-1209.
12. Kay A, Zoulim F. 2007. Hepatitis B virus genetic variability and evolution. Virus Res 127:164-176.
13. Li K, Zoulim F, Pichoud C, Kwei K, Villet S, Wands J, Li J, Tong S. 2007. Critical role of the 36-nucleotide insertion in hepatitis B virus genotype G in core protein expression, genome replication, and virion secretion. J Virol 81:9202-9215.
14. Liaw YF, Chu CM. 2009. Hepatitis B virus infection. Lancet 373:582-592.
15. Lin CL, Kao JH. 2008. Hepatitis B viral factors and clinical outcomes of chronic hepatitis B. J Biomed Sci 15:137-145.
16. McGovern BH. 2007. The epidemiology, natural history and prevention of hepatitis B: Implications of HIV coinfection. Antivir Ther 12:H3-H13.
17. Price JC, Thio CL. 2010. Liver disease in the HIV-infected individual. Clin Gastroenterol Hepatol 8:1002-1012.
18. Revill PA, Littlejohn M, Ayres A, Yuen L, Colledge D, Bartholomeusz A, Sasaduesz J, Lewin SR, Dore GJ, Matthews GV, Thio CL, Locarnini SA. 2007. Identification of a novel hepatitis B virus precore/core deletion mutant in HIV/hepatitis B virus co-infected individuals. AIDS 21:1701-1710.
19. Sa-Nguanmoo P, Thongmee C, Ratanakorn P, Pattanarangsan R, Boonyarittichaikij R, Chodapisitkul S, Theamboonlers A, Tangkijvanich P, Poovorawan Y. 2008. Prevalence, whole genome characterization and phylogenetic analysis of hepatitis B virus in captive orangutan and gibbon. J Med Primatol 37:277-289.
20. Sa-Nguanmoo P, Tangkijvanich P, Thawornsuk N, Vichaiwattana P, Prianantathavorn K, Theamboonlers A, Tanaka Y, Poovorawan Y. 2010. Molecular epidemiological study of hepatitis B virus among migrant workers from Cambodia, Laos, and Myanmar to Thailand. J Med Virol 82:1341-1349.
21. Sa-Nguanmoo P, Tangkijvanich P, Tharmaphornpilas P, Rasdjarmrearnsook AO, Plianpanich S, Thawornsuk N, Theamboonlers A, Poovorawan Y. 2012. Molecular analysis of hepatitis B virus associated with vaccine failure in infants and mothers: A case-control study in Thailand. J Med Virol 84:9.
22. Simmonds P, Midgley S. 2005. Recombination in the genesis and evolution of hepatitis B virus genotypes. J Virol 79:15467-15476.
23. Suwannakarn K, Tangkijvanich P, Theamboonlers A, Abe K, Poovorawan Y. 2005. A novel recombinant of Hepatitis B virus genotypes G and C isolated from a Thai patient with hepatocellular carcinoma. J Gen Virol 86:3027-3030.
24. Tanaka Y, Mukaide M, Orito E, Yuen M, Ito K, Kurbanov F, Sugauchi F, Asahina Y, Izumi N, Kato M, Lai C, Ueda R, Mizokami M. 2006. Specific mutations in enhancer II/core promoter of hepatitis B virus subgenotypes C1/C2 increase the risk of hepatocellular carcinoma. J Hepatol 45:646-653.
25. Tangkijvanich P, Mahachai V, Komolmit P, Fongsarun J, Theamboonlers A, Poovorawan Y. 2005. Hepatitis B virus genotypes and hepatocellular carcinoma in Thailand. World J Gastroenterol 11:2238-2243.
26. Thio CL. 2009. Hepatitis B and human immunodeficiency virus coinfection. Hepatology 49:S138-S145.
27. Tuma P, Pineda JA, Labarga P, Vidal F, Rodriguez C, Poveda E, Santos J, Gonzalez-Garcia J, Sobrino P, Tural C, Soriano V. 2011. HBV primary drug resistance in newly diagnosed HIV-HBV-coinfected individuals in Spain. Antivir Ther 16:585-589.
28. Wai CT, Fontana RJ. 2004. Clinical significance of hepatitis B virus genotypes, variants, and mutants. Clin Liver Dis 8:321-352.
29. Yuen MF, Tanaka Y, Shinkai N, Poon RT, But DY, Fong DY, Fung J, Wong DK, Yuen JC, Mizokami M, Lai CL. 2008. Risk for hepatocellular carcinoma with respect to hepatitis B virus genotypes B/C, specific mutations of enhancer II/core promoter/precore regions and HBV DNA levels. Gut 57:98-102.